Case report: Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 20, Issue 9, 1997, Pages 805-807

  Toren, A ^a   Nagler, A ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Ascites; Chronic GVHD; Pericardial effusion; Pleural effusion; Polyserositis

Indexed keywords

HLA A2 ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASCITES; AUTOIMMUNITY; CASE REPORT; CHILDHOOD LEUKEMIA; ETIOLOGY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYARTHRITIS; PRIORITY JOURNAL; SCHOOL CHILD; ACUTE LYMPHOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CHILD;

BONE MARROW TRANSPLANTATION; CHILD; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEPRILYSIN; PERICARDIAL EFFUSION;

EID: 0030613861     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700960     Document Type: Article

References (13)

1. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
2. Sullivan KM, Witherspoon RP, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72: 546-554.
3. Shulman HM, Sullivan KM Weiden PL et al. Chronic graft-versus-host syndrome in man. Am J Med 1980; 69: 204-217.
4. Waldman H, Polliack A, Hale G. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal anti-human lymphocyte antibody (Campath-1). Lancet 1984; ii: 483.
5. Nagler A, Segal V, Slavin S, Levi-Schaffer F. Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts. Clin Exp Immunol 1995; 100: 529-535.
6. Veys PA, McAvinchey R, Rothman MT. Pericardial effusion following conditioning for bone marrow transplantation in acute leukemia. Bone Marrow Transplant 1987; 2: 213-216.
7. Einsele H, Ehinger C, Vallbracht A. Isolated pericardial relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 1989; 4: 323-325.
8. Tamura T, Kanamori H, Yamazaki E et al. Cold agglutinin disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 321-323.
9. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant 1996; 17: 207-211.
10. Falk K, Rotzschke O, Takiguchi M et al. Peptide motifs of HLA-B51, B-52 and B-78 molecules, and implications for Behcet's disease. Int Immunol 1995; 7: 223-228.
11. Skarsvag S, Hansen KE, Moen T, Eggen BM. Distribution on HLA class II alleles in autoantibody subsets among Norwegian patients with systemic lupus erythematosus. Scand J Immunol 1995; 42: 564-571.
12. Smikle MF, Barton EN, DeCeulaer K et al. Systemic lupus erythematosus, rheumatoid arthritis and HLA phenotypes in Jamaicans. West Indian Med J 1995; 44: 11-13.
13. Williams RC Jr, Malone CC, Kao KJ. IgM rheumatoid factors react with human class I HLA molecules. J Immunol 1996; 156: 1684-1694.